A common asthma inhaler powered by a new propellant is safe and effective but could come at nearly triple the cost to consumers until a generic version hits the market, according to a review in today’s (March 29) New England Journal of Medicine.
The benefits of full-scale adoption of health information technology (HIT) will be significant, leading to a higher standard of quality in the U.S. health care system, Lynne M. Kirk, MD, FACP, president of the American College of Physicians (ACP), today told a hearing of the Subcommittee on Regulations, Healthcare and Trade of the House Committee on Small Business.
Columbia University Medical Center announces today the expansion of its Lieber Center for Schizophrenia Research and the launch of a new comprehensive psychiatric care clinic at its E. 60th Street location, all made possible through a $9.2 million gift from Stephen and Constance Lieber and the Essel Foundation.
Rates of mortality for heart surgery at Oxford Radcliffe Hospitals NHS Trust are within the acceptable statistical limits, according to a report by the Healthcare Commission.
People from some black and minority ethnic groups were three times more likely than average to be admitted to mental health hospitals, results of a national census have shown.
Long waits for endoscopies have been eliminated in many parts of the UK, but some people are still waiting too long for the procedures, particularly in the south east, according to a report published by the Healthcare Commission, UK.
The University of Texas M. D. Anderson Cancer Center has joined the U.S.-Middle East Partnership for Breast Cancer Awareness and Research, a collaboration designed to increase early breast cancer detection and reduce related deaths in the region through improved awareness, increased clinical resources and world-class research.
If you want the best technology available to relieve blocked blood flow to the heart, the choice is a drug-eluting stent. And you are most likely to obtain the drug-eluting stent for reasons that have nothing to do with your medical condition, a new Mayo Clinic study shows.
Chest pain due to a shortage of blood in the heart, known as angina, is a condition that affects millions of Americans. The most recently approved new pharmaceutical approach to treat chronic angina is a novel drug called ranolazine, which was approved in 2006 for use as second line therapy in patients who continue to experience angina despite treatment with another class of anti-anginal medication.
Some day, heart attack survivors might have a patch of laboratory-grown muscle placed in their heart, to replace areas that died during their attack.